GLUT1 deficiency effects in reducing Aβ-clearance and accelerating AD pathology were due to consequent reduced expression of LRP1, a key Aβ clearance transporter, in the microvasculature [89]. The gene discussed is SLC2A1; the disease is Alzheimer disease.